Main Article Content
Background: Mortality, severity, and recovery of COVID-19 are the main concern all over the world and are still not fully understood, particularly in the Middle East area.
Objective: To analyze the prevalence and the characteristics of COVID-19 in Assiut Province in Egypt.
Patients and Methods: This is a retrospective study that includes RT-q PCR- confirmed COVID-19 cases during the period from March7th 2020 to September17th 2020 in Assiut Province.
Results: A total of 1201 cases are confirmed out of 2750 suspected cases. The breakdown of the cases is as follows; 84% fully recovered, 14.6% died and 1.4% are still in quarantine at the time of writing this article. Severe cases occur in old ages with no deaths below 21 years of age. Male and female deaths are 59.4% and 40% respectively. The associated co-morbidities are mainly chronic obstructive pulmonary disease, diabetes mellites, heart failure, ischemic heart disease, and obesity.
Conclusion: The total percentage of infection in Assiut is 0.04%; it is lower than the percentage of the total infection in the country (0.1%). Respiratory failure is the leading cause of death in all patients.
Chan JWM, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax. 2003;58:686–689.
Alzoubi H, Alnawaiseh N, Al-Mnayyis A, Abu- Lubada M, Aqel A, Al-Shagahin H. COVID-19 - knowledge, attitude and practice among medical and non-medical university students in jordan. J Pure Appl Microbiol. 2020;14(1):17–24.
Mahase E. COVID-19: death rate is 0.66% and increases with age, study estimates. BMJ. 2020;369:m1327.
Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95.
Guan GW, Gao L, Wang JW, et al. Exploring the mechanism of liver enzyme abnormalities in patients with novel coronavirus-infected pneumonia. Zhonghua Gan Zang Bing Za Zhi. 2020;28(2):100–106.
Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicatingperson-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523.
Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020; 8(1):e35.
Marhl M, Grubelnik V, Magdič M, Markovič R. Diabetes and metabolic syndrome as risk factors for COVID-19. Diabetes Metab Syndr. 2020;14(4):671–677.
Schmidt FM, Weschenfelder J, Sander C, et al. Inflammatory cytokines in general and central obesity and modulating effects of physical activity. PLoS One. 2015;10(3): e0121971. DOI:10.1371/journal.pone.0121971
Cascella M, Rajnik M, Cuomo A, Dulebohn S, Napoli RD. Features, evaluation and treatment coronavirus (COVID-19). stat pearls: treasure Island, stat pearls publishing; 2020.
Pan F, Ye T, Sun P, et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology. 2020;295(3):715–721.
Li J, Fan JG. Characteristics and mechanism of liver injury in 2019 coronavirus disease. J Clin Transl Hepatol. 2020;8(1):13‐17.
Senjo H, Higuchi T, Okada S, Takahashi O. Hyperferritinemia: causes and significance in a general hospital. Hematology. 2018;23(10):817–822.
Zhou F, Yu T, Du R, Fan G, Liu Y. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054e62.
Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism and COVID-19 pneumonia: a random association?. Eur Heart J. 2020;ehaa254. DOI: 10.1093/eurheartj/ehaa254.
Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospitalization and critical illness among 4103 patients with COVID-19 disease in New York City. Med Rxiv; 2020.